← Open Payments lookup

CAROLYN HOWELL: Open Payments

NPI 1932368735 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$543 in 24 payments from 11 companies in 2025. Trend: 2023 $62 · 2024 $30 · 2025 $543

Food & beverage: $543
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$98
Corium, LLC4$98
Vanda Pharmaceuticals Inc.3$74
Neurocrine BioSciences, Inc.2$53
Tris Pharma Inc3$48
ABBVIE INC.2$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$34
Collegium Pharmaceutical, Inc.2$33
Teva Pharmaceuticals USA, Inc.1$25
E.R. Squibb & Sons, L.L.C.1$18

Products named: Azstarys, INGREZZA, ABILIFY ASIMTUFII, HETLIOZ, Dyanavel XR, ABILIFY MAINTENA, VRAYLAR, CAPLYTA.

Industry payments across MD — which companies pay providers there.